Company Overview of Zydus Pharmaceuticals (USA) Inc.
Zydus Pharmaceuticals (USA) Inc. operates as a generic pharmaceutical company that discovers, develops, manufactures, and markets various healthcare therapies/generic pharmaceutical products to customers in the United States. The company was incorporated in 2003 and is based in Pennington, New Jersey. Zydus Pharmaceuticals (USA) Inc. operates as a subsidiary of Cadila Healthcare Limited.
73 Route 31 North
Pennington, NJ 08534
Founded in 2003
Key Executives for Zydus Pharmaceuticals (USA) Inc.
Zydus Pharmaceuticals (USA) Inc. Key Developments
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Zydus Pharmaceuticals (USA) Inc., please visit www.zydususa.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.